Search GMMMG

ADHD medicines shortages – guidance and information

In response to the national supply shortage of prescribed medication for ADHD, a GM task and finish group led the development of the following supporting guidance:

  • National Supply Shortage of prescribed medication for ADHD – A Guide for Secondary Care
  • GM Pathway for the management of patients prescribed medicines for ADHD during the national shortage – primary care guidance
  • Patient information – “National Supply Shortage of your prescribed medication for ADHD”

This guidance is now available below.

Document Title Issue Date Review Date Status
Primary care: Pathway for the Management of Patients Prescribed Medicines for ADHD during the National Shortage 20231101 Nov 2023
Primary care letter template: to inform patients of a switch from a branded generic methylphenidate MR tablet preparation to an alternative 20231101 Nov 2023
Secondary care: National supply shortage of prescribed medication for ADHD 20231101 Nov 2023
Patient information leaflet: National Supply Shortage of your prescribed medication for ADHD 20231101 Nov 2023